The Cancer Centre at Clínic Barcelona obtains OECI accreditation as a Comprehensive Cancer Centre
This European recognition endorses centres that integrate cancer care, research, education and innovation under the most demanding quality standards.
News from Institute of Cancer and Blood Diseases
Hospital Clínic to commemorate the 50th anniversary of the first allogeneic transplant on 9 June
The event will bring together healthcare professionals, institutional representatives and patients to review five decades of advances in haematopoi...
Antitumor activity of RAS inhibitors described for the first time in preclinical models of cholangiocarcinoma
A team from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre, has participated in an international study th...
The Chair of Innovation in Precision Oncology celebrates five years of advancing training, research and leadership in precision medicine
March 2026 marks five years since the creation of the Chair of Innovation in Precision Oncology (IOP), a strategic initiative of the University of...
World Colorectal Cancer Day: two studies from the COLONPREV project provide new insights to improve prevention
Today is World Colorectal Cancer Day, which aims to raise awareness about the disease and emphasises the importance of prevention and screening as...
Clínic-IDIBAPS optimizes its academic CAR-T therapy against multiple myeloma to address relapse
Researchers from Clínic-IDIBAPS, as part of the Clínic Barcelona Comprehensive Cancer Centre — a centre driven by Clínic, IDIBAPS and the Universit...
Hospital Clínic marks 25 years of home-based haematology care
The Home Care Unit (UAD) of the Clínic Barcelona Comprehensive Cancer Centre marked its 25th anniversary on 5 March 2026 with a commemorative event...
February: Cholangiocarcinoma Awareness Month
February, particularly February 19, is dedicated to raising awareness about cholangiocarcinoma, a rare tumour in our setting where most patients ar...
Viro-immunotherapy combination shows promising results in breast cancer patients with poor initial chemotherapy response
A study led by Clínic Barcelona Comprehensive Cancer Centre (4CB)- – driven by Clínic Barcelona, IDIBAPS and UB-, and sponsored by SOLTI, shows tha...
CAR-T ARI-0001 shows high response rates in adult patients with acute lymphoblastic leukemia
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...